BridgeMD
New treatment option for Prolapse; Female
Official title Functional Links Between the Temporomandibular Joint and the Pelvis in Gynecology
ClinicalTrials.gov ID: NCT05978414
What this study is testing
- What it's testing
- 1 Recruitment. 2.
- You might receive a placebo (an inactive treatment) instead of the study drug.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 60, women only
You may be able to join if
- Written consent to participate in the study.
- Female patients after surgical treatment with prolapse of reproductive organs and diagnosed endometriosis.
You likely can't join if
- No written consent to participate in the study.
- Cancer.
- Injury to the temporomandibular joint and pelvis.
- Fibromyalgia.
- Rheumatic diseases.
- At each stage of the experiment if the patient decides that she does not want to participate she is excluded.
The study team makes the final eligibility decision.
Where it's taking place
- Poznan, Poland
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 18 years to 60 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Poznan, Poland. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.